Rezultati pretraživanja
  1. 3. velj

    [SEQENS CDMO] The growth of the generic drug marketplace : A win-win for the industry and patients. Discover the analyse of Laurent Alexandre, Director, Proprietary APIs, at Seqens CDMO on our blog 👇

  2. prije 23 sata

    At Custom Pharma we are licensed for the manufacture of veterinary medication, we're working on some exciting projects so make sure you follow us and you can click the link below to sign up to our mailing list!

  3. prije 3 sata

    could produce much larger volumes at a reduced cost ‼️ we are the leader using . Breaking news:

  4. prije 8 sati

    Meet the Kemwell team at Annual Biologics Manufacturing Asia 2020 Singapore. To know more details contact the Kemwell team. . . Girish Joshi, PhD, Jaby Jacob, Sanjay Lodha, Rachit Gunderia .

  5. prije 19 sati
  6. 5. velj

    Nice, short summary of 3 keys in selecting a CDMO.

  7. 5. velj

    Kemwell’s team of experienced scientists strive to develop a robust, efficient, scaled up manufacturing process to deliver consistent product quality. . .

  8. 4. velj

    EXPERTISE CHOSEN TO DELIVER 100% DATA DRIVEN - The strength of Quay is our people. We invest in the best. Only experts with strong scientific backgrounds, years of extensive knowledge underpins the service we deliver. Find out more

  9. 4. velj
  10. 4. velj
  11. 3. velj

    Breaking: Catalent to buy Orgenesis' biz Masthercell for $315m - story Insider

  12. 3. velj

    Kemwell Vision is to be a global leader and first-choice CDMO for biologics. . .

  13. 31. sij

    Our latest blog post is all about understanding reprogramming to generate iPSCs and how to get them ready.

  14. 31. sij

    This month's BPOR includes the launch of $1.1billion The Center for Breakthrough Medicines for

  15. 31. sij

    New technological investments are a tangible sign of our ability to continue to focus on custom development and manufacturing (), at the same time enhancing the human capital of our operators in terms of dedication and know-how.

    Prikaži ovu nit
  16. 31. sij

    Coripharma and Midas to cooperate on sales & marketing for pharmaceutical contract manufacturing of finished dosage forms.

  17. 30. sij

    To optimize workflow of customer projects, we align our development service laboratory portfolio under one roof. Further expansion of laboratory space will continue throughout 2020.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.